Curie.Bio is a venture capital firm that helps founders discover and develop important new medicines. We do this by investing directly into existing companies, creating focused spinouts, and helping founders build companies from scratch. With $1B under management for seed and Series A rounds, and a 100-person team whose expertise has contributed to more than 40 FDA-approved drugs, we work side by side with founders to reach critical milestones in a highly capital-efficient way.
| Website | https://www.curie.bio |
| Employees | 141 (114 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology Research |
| Keywords | Biotechnology Venture Capital, Life Sciences Venture Capital, Seed Stage Investing, Drug Development Funding, Pharmaceutical Venture Capital, Therapeutic Innovation, Innovative Therapeutics, Pharmaceutical Startups, Biotech Funding, Drug Discovery, Therapeutics Investment, Venture Firm, Biotech Startups, Seed Funding |
| Competitors | Amgen, Moderna Therapeutics, Elekta, insitro, LanzaTech, Geno, Zymergen, Inc., Synlogic, Arzeda, Ecovative +33 more (view full list) |
Looking for a particular Curie.Bio employee's phone or email?
Semi Trotto is the Chief People Officer of Curie.Bio.
114 people are employed at Curie.Bio.